Skip to main content

Century Therapeutics, Inc.

IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001850119

In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Century Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
+2 vs. Q4 2021
Shares held
22.2M
+1.01M (+4.8%) vs. Q4 2021
Total value
$278.9M
−$56.3M (−16.8%) vs. Q4 2021
New holders
8
21 more added
Sold out
6
11 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IPSC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 52 institutions
Q1 2021: 0 institutionsQ2 2021: 36 institutionsQ3 2021: 49 institutionsQ4 2021: 50 institutionsQ1 2022: 52 institutionsQ2 2022: 56 institutionsQ3 2022: 54 institutionsQ4 2022: 65 institutionsQ1 2023: 64 institutionsQ2 2023: 64 institutionsQ3 2023: 55 institutionsQ4 2023: 63 institutionsQ1 2024: 67 institutionsQ2 2024: 61 institutionsQ3 2024: 67 institutionsQ4 2024: 72 institutionsQ1 2025: 70 institutionsQ2 2025: 65 institutionsQ3 2025: 57 institutionsQ4 2025: 47 institutionsQ1 2026: 72 institutionsQ2 2026: 100 institutions
Value heldQ1 2022: $278.9M
Q1 2021: $0Q2 2021: $490.8MQ3 2021: $496.2MQ4 2021: $335.2MQ1 2022: $278.9MQ2 2022: $182.8MQ3 2022: $208.7MQ4 2022: $107.2MQ1 2023: $69.5MQ2 2023: $61.0MQ3 2023: $36.1MQ4 2023: $58.7MQ1 2024: $96.6MQ2 2024: $102.3MQ3 2024: $67.8MQ4 2024: $36.8MQ1 2025: $14.1MQ2 2025: $12.6MQ3 2025: $10.1MQ4 2025: $25.6MQ1 2026: $315.6MQ2 2026: $387.0M
Institutions holding IPSC and their total value by quarter
QuarterHoldersValue
Q2 2026100$387.0M
Q1 202672$315.6M
Q4 202547$25.6M
Q3 202557$10.1M
Q2 202565$12.6M
Q1 202570$14.1M
Q4 202472$36.8M
Q3 202467$67.8M
Q2 202461$102.3M
Q1 202467$96.6M
Q4 202363$58.7M
Q3 202355$36.1M
Q2 202364$61.0M
Q1 202364$69.5M
Q4 202265$107.2M
Q3 202254$208.7M
Q2 202256$182.8M
Q1 202252$278.9M
Q4 202150$335.2M
Q3 202149$496.2M
Q2 202136$490.8M
Q1 20210$0

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Century Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding IPSC in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC8,229,291$103.6M0.01%+33,088+0.4%Added
Casdin Capital, LLC3,206,380$40.4M1.81%00.0%Unchanged
Federated Hermes, Inc.1,164,094$14.7M0.03%00.0%Unchanged
BlackRock Inc.1,028,257$12.9M0.00%+200,834+24.3%Added
Deep Track Capital, LP926,469$11.7M0.75%+676,469+270.6%Added
Ra Capital Management, L.P.914,094$11.5M0.25%00.0%Unchanged
Avidity Partners Management LP865,000$10.9M0.24%+13,478+1.6%Added
Vanguard Group Inc819,762$10.3M0.00%+271,760+49.6%Added
Marshall Wace, LLP701,338$8.83M0.02%00.0%Unchanged
Octagon Capital Advisors LP658,266$8.29M1.79%−44,357−6.3%Reduced
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)614,095$7.73M0.16%00.0%Unchanged
Logos Global Management LP550,259$6.93M0.90%−63,836−10.4%Reduced
Point72 Asset Management, L.P.467,390$5.88M0.03%+56,590+13.8%Added
Morgan Stanley383,502$4.83M0.00%−62,914−14.1%Reduced
Geode Capital Management, LLC267,905$3.37M0.00%+52,581+24.4%Added
DAFNA Capital Management LLC256,892$3.23M0.84%+156,757+156.5%Added
State Street Corp222,033$2.79M0.00%+33,885+18.0%Added
Woodline Partners LP208,082$2.62M0.04%00.0%Unchanged
Northern Trust Corp134,484$1.69M0.00%+31,317+30.4%Added
Charles Schwab Investment Management Inc91,182$1.15M0.00%+13,681+17.7%Added
JPMorgan Chase & Co59,119$744.0K0.00%−81,834−58.1%Reduced
Walleye Capital LLC50,908$641.0K0.02%−11,563−18.5%Reduced
Bank of America Corp45,755$575.0K0.00%+4,629+11.3%Added
Bank of New York Mellon Corp43,881$552.0K0.00%+10,524+31.5%Added
Citadel Advisors LLC32,458$409.0K0.00%+32,458New
Nuveen Asset Management, LLC24,990$290.0K0.00%+8,289+49.6%Added
D. E. Shaw & Co., Inc.22,437$282.0K0.00%+7,400+49.2%Added
Goldman Sachs Group Inc20,746$261.0K0.00%+2,091+11.2%Added
Rhumbline Advisers14,961$188.0K0.00%+14,961New
HarbourVest Partners LLC14,631$184.0K0.04%00.0%Unchanged
Allspring Global Investments Holdings, LLC13,908$175.0K0.00%−1,637−10.5%Reduced
Wells Fargo & Company13,908$175.0K0.00%−943−6.3%Reduced
New York State Common Retirement Fund13,651$172.0K0.00%+5,933+76.9%Added
MetLife Investment Management12,167$153.2K0.00%+12,167New
Parametric Portfolio Associates LLC11,589$146.0K0.00%+11,589New
Deutsche Bank AG10,353$131.0K0.00%+3,178+44.3%Added
American International Group, Inc.8,604$108.0K0.00%+2,328+37.1%Added
California State Teachers Retirement System7,401$93.0K0.00%+1,020+16.0%Added
Hershey Trust Co4,723$59.0K0.00%00.0%Unchanged
Barclays PLC2,815$36.0K0.00%+2,815New
STRS Ohio2,700$33.0K0.00%00.0%Unchanged
Citigroup Inc1,843$23.0K0.00%−2,891−61.1%Reduced
Amalgamated Bank1,720$22.0K0.00%+1,720New
Amalgamated Financial Corp.1,720$22.0K0.00%+1,720New
Legal & General Group Plc1,660$21.0K0.00%+555+50.2%Added
Metropolitan Life Insurance Co1,426$18.0K0.00%+1,426New
Royal Bank of Canada1,065$13.0K0.00%−1,683−61.2%Reduced
Ameritas Investment Partners, Inc.905$11.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)794$10.0K0.00%−2,271−74.1%Reduced
Daiwa Securities Group Inc.159$2.00K0.00%00.0%Unchanged
Patriot Financial Group Insurance Agency, LLC65$1.00K0.00%00.0%Unchanged
UBS Group AG32$00.00%−5,496−99.4%Reduced
OrbiMed Advisors LLC0$00.00%−307,047−100.0%Sold out
Parametrica Management Ltd0$00.00%−28,855−100.0%Sold out
Royce & Associates LP0$00.00%−12,900−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−12,300−100.0%Sold out
ProShare Advisors LLC0$00.00%−10,273−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−200−100.0%Sold out